Filing Flows › Neuronetics (STIM) › Q2 2026
Neuronetics (STIM) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Neuronetics (STIM) reported revenue of $41.6M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +21% from the quarter before. Operating margin was -3.6%, net loss $3.5M (8.3% of revenue).
Neuronetics, Q2 2026: revenue $41.6M (+9% year over year), operating margin -3.6%, net loss $3.5M, operating cash flow −$1.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41.6M | +21% | +9% |
| Operating profit | −$1.5M | — | — |
| Net earnings | −$3.5M | — | — |
| Operating cash flow | −$1.0M | — | — |
What changed
Revenue was $41.6M in Q2 2026, up 9% year over year and up 21% from the previous quarter. Service was the largest line at 65% of revenue. Service added $3.9M year over year (up 17%), 112% of the total change. NeuroStar declined 3%.
Gross margin was 51.1%, up 4.5 points from Q2 2025. Operating costs exceeded revenue by $1.5M, an operating margin of -3.6%. Operating expenses fell 12% while revenue rose 9%. The quarter ended with a net loss of $3.5M, narrower than the previous quarter's $10.8M loss. Net interest and other expense of $2.0M was the main reason.
Operating cash flow was −$1.0M. Non-cash charges added back $729K of depreciation and amortization and $688K of share-based compensation. Working capital and other items added $1.0M. Capital expenditures of $417K exceeded it, leaving free cash flow of −$1.4M.
Questions
What was Neuronetics' revenue in the second quarter 2026?
Neuronetics (STIM) reported revenue of $41.6M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +21% from the quarter before.
Was Neuronetics profitable in the second quarter 2026?
Operating loss was $1.5M (-3.6% of revenue) and net loss $3.5M.
Source: Neuronetics 10-Q on SEC EDGAR.